These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3799112)

  • 1. [Effectiveness of measles immunoprophylaxis and the criteria for assessing its possible elimination].
    Sokhin AA; Sliusar' LI; Ignatov SA; Mekhova LS
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Nov; (11):24-30. PubMed ID: 3799112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serological study of postvaccinal measles immunity in the absence of a booster effect and in measles foci].
    Chudnaia LM; Fastovskaia BN; Shekhter AB; Orekhova GI; Dzhulaĭ AS
    Tr Inst Im Pastera; 1979; 53():71-5. PubMed ID: 262711
    [No Abstract]   [Full Text] [Related]  

  • 3. [The results of multiyear observations on the duration of the maintenance of immunity in those vaccinated and revaccinated against and recovered from measles].
    Sliusar' LI; Sokhin AA; Radomskaia FS; Degtiareva GV; Panasenko LI; Litvinova TP; Komarevskaia RV; Bol'shinskaia ZhI
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Aug; (8):66-70. PubMed ID: 2239007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The duration and strength of postvaccinal measles immunity].
    Bolotovskiĭ VM; Gelikman BG; Auzinia AV; Glinskaia EV
    Zh Mikrobiol Epidemiol Immunobiol; 1990 May; (5):32-7. PubMed ID: 2386001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of consultative offices on immunoprophylaxis in organizing epidemiologic surveillance of measles].
    Ignatov SA; Radomskaia FS; Makarova EN; Leĭko AP; Itkina EN; Komarevskaia RV
    Vrach Delo; 1990 Jan; (1):121-3. PubMed ID: 2330697
    [No Abstract]   [Full Text] [Related]  

  • 6. [Epidemiologic effectiveness of mass revaccination against measles].
    Deshevoĭ SE; Rykushin IuP; Ovsiannikova IV; Malykhina RM; Pogorelyĭ IuA
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Aug; (8):69-72. PubMed ID: 2973716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The duration and intensity of measles immunity after a repeat inoculation against this infection].
    Bolotovskiĭ VM; Mikheeva IV; Gelikman BG; Auzinia AV; Glinskaia EV
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Apr; (4):45-9. PubMed ID: 2385988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunological effectiveness of a booster inoculation against measles in children remaining seronegative after vaccination].
    Bolomovskiĭ VM; Gelikman BG; Titova NS; Slavnitskaia IV; Auzinia AV
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jul; (7):100-6. PubMed ID: 6333122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transplacental measles immunity in infants in the 1st year of life].
    Bystriakova LV; Zaĭtseva RV; Kolobova LV; Pushkareva EA; Smorodinova IP
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Oct; (10):50-2. PubMed ID: 1839342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Measles morbidity among children inoculated against this infection].
    Bolotovskiĭ VM; Gelikman BG; Mikheev IV; Titova NS; Kikosh GV
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Mar; (3):38-43. PubMed ID: 3705811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Postvaccinal antimeasles immunity in children with allergic diseases].
    Kostinov MP; Sadykova DK; Balabolkin II; Ignat'eva GV; Gervazieva VB; Gerasimova AG; Agapushkina GG
    Vopr Virusol; 1990; 35(6):512-3. PubMed ID: 2082559
    [No Abstract]   [Full Text] [Related]  

  • 12. [Measles epidemiology and the status of specific immunity in Novgorod Province during a mass immunization].
    Golubeva LI; Brantseva IV
    Tr Inst Im Pastera; 1985; 62():68-72. PubMed ID: 2954277
    [No Abstract]   [Full Text] [Related]  

  • 13. Population immunity to measles in the United States, 1999.
    Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A
    J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The validation of the expediency of a review of the times for revaccinating children against measles].
    Rusakova EV; Bezuglova MS; Vasil'eva VI; Frank KD; Drynov ID; Filatov NN; Demskiĭ VI
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Aug; (8):51-4. PubMed ID: 1950287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The epidemiological efficacy of mass vaccination against measles among the troops].
    Sibilev VI; Shevtsova VA; Tiasto EA
    Voen Med Zh; 1994 Feb; (2):50-1, 80. PubMed ID: 8165796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Postvaccinal immunity study of children inoculated with a live measles vaccine].
    Bol'shakova SL
    Tr Inst Im Pastera; 1979; 53():75-8. PubMed ID: 162466
    [No Abstract]   [Full Text] [Related]  

  • 18. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus.
    Christenson B; Böttiger M
    Vaccine; 1994 Feb; 12(2):129-33. PubMed ID: 8147093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on the persistence of immunity 15 years after revaccination with measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):392-5. PubMed ID: 2598096
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunity to measles before and after MMR booster or primary vaccination at 12 years of age in the first generation offered the 2-dose immunization programme.
    Broliden K; Levén B; Arneborn M; Böttiger M
    Scand J Infect Dis; 1998; 30(1):23-7. PubMed ID: 9670354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.